Enter your terms above and click the 'Search' button.

Showing articles 0 to 13 of 13 Filter Applied: immunomodulation (Click to remove) Acute Encephalitis in Immunocompetent Adults Lancet 393:702-716, Venkatesan, A.,et al, 2019 Autoimmune Epilepsy Arch Neurol 69:582-593,565, Quek, A.M.L.,et al, 2012 Drug Reaction with Eosinophilia and Systemic Symptoms after Daclizamub Therapy Neurol 91:e359-e363, Rauer,S.,et al, 2018 Morvan Syndrome as a Paraneoplastic Disorder of Thymoma with Anti-CASPR2 antibodies Lancet 389:1367-1368, Vale, T.C.,et al, 2017 CNS Posttransplant Lymphoproliferative Disorder Neurol 89:e32-e37, Kesari, N.K.,et al, 2017 Effect of high-dose Simvastatin on Brain Atrophy and Disability in Secondary Progressive Multiple Sclerosis (MS-STAT): A Randomised, Placebo-Controlled, Phase 2 Trial Lancet 383:2213-2221, Chataway, J.,et al, 2014 Varicella-Zoster Virus Encephalitis and Vasculopathy in a Patient Treated with Fingolimod Neurol 79:2002-2004,1942, Ratchford, J.,et al, 2012 Atypical manifestations and poor outcome of herpes simplex encephalitis in the immunocompromised Neurol 79:2125-2132, Tan, L.,et al, 2012 Mechanisms of Fingolimods Efficacy and Adverse Effects in Multiple Sclerosis Ann Neurol 69:759-777, Cohen, J.A. & Chun, J., 2011 Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis NEJM 365:1293-1303, OConnor, P.,et al, 2011 Infectious and Non-Infectious Neurologic Complications in Heart Transplant Recipients Medicine 89:166-175, Mu�oz,P., et al, 2010 Clinicopath Conf., Endheim-Chester Disease NEJM 359:736-747, Case 25-2008, 2008 Assessment: The Use of Natalizumab (Tysabri) for the Treatment of Multiple Sclerosis (An Evidence-Based Review): Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology Neurol 71:766-773, Goodin,D.S.,et al., 2008 Showing articles 0 to 13 of 13